Venstre ventrikkel hypertrofi ved isolert systolisk hypertensjon
- Prosjektnummer
- 2008060
- Ansvarlig person
- Sverre E. Kjeldsen
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Doktorgradsstipend
- Helsekategori
- Cardiovascular
- Forskningsaktivitet
- 6. Treatment Evaluation
Regression of ECG-LVH is associated with lower risk of new-onset heart failure and mortality in patients with isolated systolic hypertension; The LIFE study.
Am J Hypertens 2012 Oct;25(10):1101-9. Epub 2012 jun 21
PMID: 22717544 - Inngår i doktorgradsavhandlingen
Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study.
Hypertension 2012 Aug;60(2):347-53. Epub 2012 jul 2
PMID: 22753219 - Inngår i doktorgradsavhandlingen
Echocardiographic demonstration of improved myocardial function early after coronary artery bypass graft surgery.
Interact Cardiovasc Thorac Surg 2011 Jun;12(6):946-51. Epub 2011 mar 21
PMID: 21422155
Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study.
J Hum Hypertens 2011 Mar;25(3):178-85. Epub 2010 mai 27
PMID: 20505749 - Inngår i doktorgradsavhandlingen
Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
Am J Hypertens 2010 Aug;23(8):845-51. Epub 2010 apr 29
PMID: 20431530
ASSOCIATION OF PULSE PRESSURE WITH NEW-ONSET ATRIAL FIRBRILLATION IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY: TH
Submitted
Reduced ECG-LVH during Antihypertensive Therapy is Associated with less New-Onset Heart Failure and Mortality in Patients with I
Submitted
Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The LIFE Study
Am J Hypertens. 2010 Aug;23(8):845-51.
Regression of left ventricular hypertrophy in patients with isolated sysolic hypertension. The LIFE study
J Hypertens 2008; 26: S265
Serum uric acid predicts new-onset diabetes in hypertensive patients with left ventricular hypertrophy: the LIFE Study
J Hypertens 2009; 27 (suppl. 4): S172
Systolic blood pressure reduction during antihypertensive therapy and the prediction of new-onset atrial fibrillation in patient
J Hypertens 2009; 27 (suppl. 4): S317
Association of pulse pressure with new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy:
Eur Heart J 2009;Vol.30(Abstract Supplement):144
Reduced ECG-LVH during antihypertensive therapy is associated with less hospitalization for heart failure in patients with isola
J Hypertension 2010; 28 (e-Suppl. A): e1
Serum uric acid predicts new-onset diabetes in hypertensive patients with left ventricular hypertrophy: the LIFE Study.
J Hypertens 2009; 27 (suppl. 4): S172.
Systolic blood pressure reduction during antihypertensive therapy and the prediction of new-onset atrial fibrillation in patient
J Hypertens 2009; 27 (suppl. 4): S317.
Association of pulse pressure with new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy:
Eur Heart J 2009;Vol.30(Abstract Supplement):144.
Regression of left ventricular hypertrophy in patients with isolated systolic hypertension. The LIFE Study.
J Hypertens 2008;26(suppl. 1):S265.
PhD
- Disputert:
- desember 2012
- Hovedveileder:
- Kristian Wachtell
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport